Within this review, we discuss the interplay of natural anti-inflammatory compounds with three core inflammatory compounds in glioma, namely, NF-κB, COX-2, and NLRP3, and how these interactions might reprogram the TME to reduce gliomagenesis, immunosuppression, and invasion. This evidence concerns the gene PTGS2 and glioma.